| Academic Education |
| 1994-2001 | Studies at University of Würzburg, Medical School; State Exam, Approbation |
| Advanced Professional Degrees |
| 2008 | Habilitation „Medical Microbiology“ |
| 2006 | Medical Specialist Recognition (Facharzt) Microbiology, Virology and Infection Epidemiology |
| 2002 | Doctoral Thesis Dr. med. (summa cum laude) |
| Positions held |
| Since 2021 | Head of Institute for Hygiene and Microbiology, Univ. of Würzburg |
| Since 2017 | Professor and Chair “Medical Microbiology and Mycology”, Univ. of Würzburg |
| Since 2017 | Affiliated Researcher and Research Group Leader, Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knoell-Institute (HKI), Jena |
| 2009-2016 | Professor for Fungal Septomics, Friedrich-Schiller-University Jena and Leibniz Institute for Natural Product Research and Infection Biology, HKI, Jena |
| 2001-2009 | M.D. / Lecturer, Institute for Hygiene and Microbiology, Univ. of Würzburg |
| Professional Activities |
| Since 2018 | Member and Vice Speaker, Executive Board, Center for Infectious Diseases Research, Würzburg, Germany |
| Since 2015 | National Delegate, Antifungal Susceptibility Testing Subcommittee, EUCAST |
| Since 2014 | Head, German National Reference Center for Invasive Fungal Infections (NRZMyk) |
| Since 2013 | Scientific Administrator, InfectControl 2020 |
| Since 2012 | Editor-in-Chief, Medical Mycology Case Reports, Member (ex officio) executive board International Society for Human & Animal Mycology (ISHAM) |
| Since 2011 | Elected Secretary of the Deutschsprachige Mykologische Gesellschaft (DMykG) |
| 2014-2016 | Speaker, Septomics Research Center, Jena |
| 2013-2015 | Member, Executive Board, Center for Sepsis Control and Care, Jena |
| Stipends and Awards |
| 2008 | Career Award, German Society for Hygiene and Microbiology |
| 2002 | Becton-Dickinson Dissertation Awards of the German Society for Hygiene and Microbiology |
| Selected Publications |
- Geißel B et al. (2018) Azole-induced cell wall carbohydrate patches kill Aspergillus fumigatus. Nat Commun 9: 3098.
|
- Cunha C et al. (2017) IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity. J Allergy Clin Immunol 140: 867-870.
|
- Moyes DL et al. (2016) Candidalysin is a fungal peptide toxin critical for muco-sal infection. Nature 532: 64-68.
|
- Linde J et al. (2015) Defining the transcriptomic landscape of Candida glabrata by RNA-Seq. Nucleic Acids Res 43: 1392-1406.
|
- Cunha C et al. (2014) Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.N Engl J Med 370: 421-432.
|
